| Bioactivity | C2 L-Erythro ceramide (d18:1/2:0) is a cell-permeable sphingolipid. C2 L-Erythro ceramide (d18:1/2:0) induces cell cycle arrest in the G0/G1 phase and inhibits cell growth[1][2]. |
| CAS | 150338-90-2 |
| Formula | C20H39NO3 |
| Molar Mass | 341.53 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Baek MY, et al. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells. Arch Pharm Res. 2001 Apr;24(2):144-9. [2]. Bielawska A, et al. Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide. J Biol Chem. 1993;268(35):26226-26232. |
C2 L-Erythro ceramide (d18:1/2:0)
CAS: 150338-90-2 F: C20H39NO3 W: 341.53
C2 L-Erythro ceramide (d18:1/2:0) is a cell-permeable sphingolipid. C2 L-Erythro ceramide (d18:1/2:0) induces cell cycle
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.